2023 Innovations in Regulatory Science Awards
Celebrating outstanding achievement in regulatory science
Each year, the Reagan-Udall Foundation for the FDA brings the regulatory science community together to recognize the leadership, scientific breakthroughs, and unwavering advocacy that helps safeguard America’s public health.
Nominations are now open for the 2023 Innovations in Regulatory Science Awards. The Awards will be presented in three categories:
Leadership Award recognizes an individual’s significant contributions, national leadership, and service in the field of regulatory science and public health.
Innovation Award honors an individual, team, or organization that has improved public health through a specific innovation in regulatory issues or science.
Advocacy/Policy Award lauds an individual, group, or organization in recognition of significant policy achievements that advance regulatory science and have a direct impact on the public.
The deadline for nominations is June 15. Full nomination criteria, submission guidelines, and nomination forms are available on the Foundation website. This year's awards will be presented at a celebration on December 5 at the Willard Hotel.
2022 – Robert Temple, MD, Senior Advisor for Clinical Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA)
2021 – Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research. U.S. Food and Drug Administration (FDA)
2020 – Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA
2019 – Theresa M. Mullin, PhD, Associate Director for Strategic Initiatives, Center for Drug Evaluation and Research, FDA
2018 – Richard Pazdur, MD, Director, Oncology Center of Excellence, FDA
2017 – Janet Woodcock, MD, Center Director, Center for Drug Evaluation and Research, FDA
2021 – Medidata Link
2021 – COVID-19 Research Database
2020 – Friends of Cancer Research
2019 – Compassionate Use Advisory Committee, Co-founded by Johnson & Johnson and New York University
2018 – Robert O’Neill, PhD, former Senior Statistical Adviser, Center for Drug Evaluation and Research, and Clinical Trials Transformation Initiative
2017 – Patrick Ryan, PhD, Senior Director and Head of Epidemiology Analytics, Janssen Research and Development
2021 – George Vradenburg, UsAgainstAlzheimer's
2021 – Patrick J. Kennedy, The Kennedy Forum
2020 – The Michael J. Fox Foundation for Parkinson’s Research
2019 – Cystic Fibrosis Foundation